Navigation Links
MedCath Corporation Reports Third Quarter Earnings
Date:8/5/2009

ng the period. MEDCATH CORPORATION SUPPLEMENTAL FINANCIAL DISCLOSURE - RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES (Unaudited) The following table reconciles Adjusted EBITDA with MedCath's income from continuing operations as derived directly from MedCath's consolidated financial statements for the three and nine months ended June 30, 2009 and 2008. Three Months Nine Months Ended June 30, Ended June 30, -------------- ------------- 2009 2008 2009 2008 ---- ---- ---- ---- (in thousands) (in thousands) Income from continuing operations $586 $4,902 $4,388 $12,678 Add: Income tax expense 536 3,469 2,998 8,917 Minority interest share of earnings of consolidated subsidiaries 2,287 3,865 9,703 12,644 Equity in net earnings of unconsolidated affiliates (2,265) (2,636) (7,044) (6,842) Interest and other income (52) (284) (218) (1,930) Loss on early extinguishment of debt - - 6,702 - Interest expense 1,151 3,862 5,339 11,658 (Gain) loss on disposal of property, equipment and other assets (26) 225 138 391 Amortization 230 149 589 411 Depreciation 7,858 7,505 23,258 22,535 Pre-opening expenses 754 149
'/>"/>
SOURCE MedCath Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
2. MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
3. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
4. MedCath Corporation to Hold Conference Call on First Quarter Results
5. MedCath Corporation Reports First Quarter Earnings
6. MedCath Plans 60-bed Expansion at TexSAn Heart Hospital
7. MedCath Announces Venture With Two New Jersey Hospitals
8. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
9. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
10. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
11. MedCath Announces Acquisition of Ownership in Arizona Cath Lab

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e-USNewswire/--WhenmostpeopleheartheacronymTMJ,the...tientsthehelptheyneed.TMJstandsfortheTemporal-Mand...connectswithyourskull(temporalbone). ,, Themost...ithchewing,clickingorpoppingofthejaw.Butmanyothers...aches,fatigue,sleepdisturbances,irritability,aloss...
(Date:11/25/2009)...wswire/--Thanksgivingmealswillbedeliveredtoapproxi...eathankstoFaithInAction/VolunteerActionforAging,ap...fSCANHealthPlan.Formorethan17yearstheseorganizatio...nksgivingmealstoseniorsinneedinLongBeach,Lakewood,...ities. ,, "Ourwarmholidaymealsaredeliveredtopeo...
(Date:11/25/2009)...cancer who were treated with cisplatin-based chemo...urological side effects and Raynaud-like phenomena... according to a new study published online Novembe...ute . , Marianne Brydy, M.D., of the Department ...gen, Norway, and colleagues conducted a cross-sect...
(Date:11/25/2009)...umatoid arthritis, could help newly diagnosed diab...5 (HealthDay News) -- A drug commonly used to trea...now also shows some promise in helping patients ne... rituximab (Rituxan), helped patients keep produci...ase had destroyed some of their pancreatic beta ce...
(Date:11/25/2009)... MISSIONSkincare ®isproudtosupportGNC,seffort...nnualSt.Jude ThanksandGiving campaign,$1fromthepur...TM)LipBalm willbedonatedtoSt.Jude.Additionally,GNC...onatcheckoutatoneoftheir5,000+retaillocationsoratG...uringtheir2009 ThanksandGiving campaign. ,, "We...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...idney disease , , EL SEGUNDO, Calif., April 23 D...ices for those diagnosed with chronic kidney disea...er online resource for kidney disease - received a...urce Center, a national clearinghouse for consumer...
...s (tube current flow) according to a patient,s bod...ic patients during CT, according to a study perfor... Cleveland, OH. , Phantoms that were 10, 16 and...de using various kVp and mAs levels. The lowest do...
...tions, LLC, a subsidiary of Wound Management Techn...ed today that it will exhibit at the 22nd Annual S...Society (SAWC/WHS) conference in Dallas April 26-2...ng of wound care clinicians in the United States. ...
...and Feeling Better , , WASHINGTON, April 23 The ...pter (LFAGW) will offer the 14th Annual Symposium ...om 9:30 a.m.-12:45 p.m. at the Carnegie Endowment ...ton area patients with lupus --- 90 percent of who...
...anipulation poses, study finds , , THURSDA...nverted adult cells into embryonic-like stem cells...manipulation. , Gene manipulation is an older meth...altering them could lead to the development of man...
...logists a fun, alternative method to using a stand... images, according to a study performed at the New...Center in New York, NY. The remote may also offer ... radiologists to navigate through patient images u...
Other Medicine News:Health News:DaVita Wins Silver in Web Health Awards 2Health News:Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas 2Health News:Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas 3Health News:LFAGW to Offer Free Lupus Symposium on May 16 for Patients and Families 2Health News:Scientists Find New Way to Create Stem Cells 2Health News:Popular gaming system may offer radiologists an alternative way to view patient images 2
(Date:11/25/2009)....25/PRNewswire-FirstCall/--HeartWareInternational,...ovideroflessinvasive,miniaturizedcirculatorysuppor...heartfailure,todayannouncedthatitisscheduledtomake...ealthCareConferenceat8:00amESTonWednesday,December...otel,December1-2. ,, AlivewebcastoftheCompany,s...
(Date:11/24/2009)...e-Asia/--ChindexInternational,Inc.,("Chindex")(Nas...estern,healthcareproductsandservicesinthePeople,sR...tendthe21stAnnualPiperJaffray,"Unplugged"HealthCar...PalaceHotel. , Managementiscurrentlyscheduled...oldone-on-onemeetingsthroughouttheday.Awebcast,oft...
(Date:11/24/2009)...re-FirstCall/--Endologix,Inc.(Nasdaq: ELGX ),devel...s,announcedtodaythatithasfiledamotiontostay,ordisc...itbroughtagainstitinOctober2009byCook,Inc.Themotio...lis,Indiana. ,, Endologixhasrequestedthatthesta...arkOffice(USPTO)conductsproceedingstore-examinethe...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2William Dwyer Named to PerfectServe Advisory Board 57496 1William Dwyer Named to PerfectServe Advisory Board 57496 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 1Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 3Cyberonics to Present at Maxim Group Growth Conference 57492 1Cyberonics to Present at Maxim Group Growth Conference 57492 2
...a,Pharmaceuticals, Inc., a privately-held biotechn...ment of novel therapeutics for cardiovascular and,... raised $60 million in a,preferred stock financing...la,s two lead antithrombotic clinical candidates, ...eloping as best-in-class compounds to,replace exis...
...ceuticals,Inc., announced today it has initiated a...asiliximab) for the treatment of noninfectious uve...inflammation of the eye. The,randomized, double-ma...afety and efficacy of Simulect as maintenance ther...l undergo tapering of concomitant,immunosuppressiv...
Other Medicine Technology:Portola Completes $60 Million Financing to Advance Its Therapeutic Programs 2Portola Completes $60 Million Financing to Advance Its Therapeutic Programs 3Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis 2
TME 66 S
TME 64 S
TME 60 S
...r individual indications. XCaliber covers a compre...novative composite plastic material, XCaliber is s...ter. This means it's easier to handle, easier to a...pre-assembled, packaged sterile, and ready to use ...
Medicine Products: